Suggested Topics within your search.
Suggested Topics within your search.
- Moral and ethical aspects 2
- ART / Digital 1
- Blogueurs vidéo 1
- Business English 1
- Business writing 1
- Childhood and youth 1
- Compagnons imaginaires 1
- Computer animation 1
- Cultural property 1
- Desertions 1
- Digital cinematography 1
- Disinformation 1
- Droit 1
- Economic policy 1
- English language 1
- Fake news 1
- Foreign economic relations 1
- Gender Identity 1
- Gender identity 1
- Historic preservation 1
- History 1
- Identity 1
- Identité 1
- Identité sexuelle 1
- Imaginary companions 1
- Intelligence service 1
- Management 1
- Mass media 1
- Media literacy 1
- Medical laws and legislation 1
-
261
-
262
-
263
-
264
A Real World Report on Intravenous High-Dose and Non-High-Dose Proton-Pump Inhibitors Therapy in Patients with Endoscopically Treated High-Risk Peptic Ulcer Bleeding
Published 2012-01-01“…This study aimed to understand the real world experiences in prescribing high-dose PPI and non-high-dose PPI for preventing rebleeding after endoscopic treatment of high-risk PU. …”
Get full text
Article -
265
-
266
Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analys...
Published 2012-12-01“…This study aimed to assess the representativeness for the real-world AF population, particularly the population eligible for anticoagulants.Design A cross-sectional database analysis.Setting Dataset derived from the General Practice Research Database (GPRD).Primary and secondary outcomes measure The proportion of real-world patients with AF who met the inclusion/exclusion criteria for RE-LY, ARISTOTLE and ROCKET-AF were compared. …”
Get full text
Article -
267
-
268
-
269
Trends in Real-World Clinical Outcomes of Patients with Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small Cell Lung Cancer (NSCLC) Receiving One or More ALK Tyrosine Kinase Inh...
Published 2024-12-01“…There was no significant difference in first-line OS between the treatment groups. In patients who received more than one line of treatment, there was a significant difference in mOS between patients who received two or more lines of ALK TKIs compared to those who received one line of ALK TKI (mOS = 55 months (95% CI, 400–987 days) and 26 months (95% CI, 1448–2644 days), respectively, HR = 4.64, <i>p</i> < 0.0001). …”
Get full text
Article -
270
Political Meanings, Identity Theory and the History of Ideas: Introducing the Issue
Published 2024-12-01“…The issue of the journal is devoted to a wide range of issues related to the history of ideas, identity issues, the multipolarity of the world, as well as the translation of value meanings and socio-cultural divisions. …”
Get full text
Article -
271
Deep patch‐wise supervision for presentation attack detection
Published 2022-09-01“…The authors extensively tested the proposed method on widely used PAD data sets—Replay‐Mobile and OULU‐NPU—and on a real‐world data set that has been collected for real‐world PAD use cases. …”
Get full text
Article -
272
Brief report: impact of consolidation durvalumab on unresectable non-small cell lung cancer with driver mutations
Published 2024-01-01“…Among the 123 patients who underwent definitive chemoradiation, 33 had common driver mutations, including EGFR mutations, ALK rearrangements, ROS1 rearrangements, and RET fusions. …”
Get full text
Article -
273
Landscape as guiding element in the design and planning of dutch colonial settlements (1600-1800)
Published 2012-01-01Get full text
Article -
274
Real-world ePRO use and clinical outcomes using electronic patient-reported symptom monitoring for patients with advanced non-small-cell lung cancer receiving first-line pembrolizu...
Published 2025-01-01“…Methods: Adults with advanced NSCLC, ECOG performance status of 0–2, who received first-line (1L) pembrolizumab (monotherapy or with chemotherapy) were eligible. …”
Article -
275
-
276
Characteristics, treatment patterns, and biomarker testing of patients with advanced RET fusion-positive non-small cell lung cancer in a real-world multi-country observational stud...
Published 2025-02-01“…IntroductionApproximately 1−2% of non-small cell lung cancers (NSCLCs) are positive for rearranged during transfection (RET) gene fusions. The aim of this real-world multi-national study was to describe clinical characteristics, biomarker testing, and treatment patterns of patients with RET fusion-positive NSCLC.MethodsThis observational study was conducted in 2020 in nine countries using electronic patient record forms, following Adelphi Disease Specific Programme (DSP™) methodology. …”
Get full text
Article -
277
Turkmen Students at Volgograd State Technical University
Published 2020-05-01“…The attractiveness of the University in the world market of educational services is an indicator of its success, which is estimated by a set of criteria including the number of foreign students studying there. …”
Get full text
Article -
278
Collective portrait of head of Omsk school for training infantry warrant officers
Published 2021-02-01Get full text
Article -
279
Is Weight Loss the Main Driver for A1C Improvement by Glucagon‐Like Peptide 1 (GLP‐1) Receptor Agonists? A 2.5‐Year Analysis in Real‐World Clinical Practice
Published 2025-01-01“…Methods We retrospectively evaluated 256 patients with T2D who were treated with exenatide (n = 84), dulaglutide (n = 99), or semaglutide (n = 73) for 2.5 years without interruption in real‐world clinical practice. …”
Get full text
Article -
280
Retrospective, Non-Interventional, Multicenter Study on the Effectiveness and Safety of Intravesical Bacillus Calmette–Guerin in Patients with Non-Muscle-Invasive Bladder Cancer: R...
Published 2024-12-01“…Conclusions: This real-world study demonstrates that SII-ONCO-BCG is an effective and safe treatment for patients with intermediate- and high-risk NMIBC.…”
Get full text
Article